US Hepatitis Diagnostics Market 2015: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures

February 2015 | 241 pages | ID: UF5A58587A6EN
Venture Planning Group

Abstracts

Complete report $3,900. DataPack (test volumes, sales forecasts, supplier shares) $2,500. The report presents a detailed analysis of the Hepatitis diagnostics market in the US.

Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed.

The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets: - Hospitals

Commercial/Private Labs

Blood Banks

Physician Offices

Public Health Labs

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns. Contains 241 pages and 14 tables

Contents

I. Introduction

II. Hepatitis

Worldwide Market and Technology Overview

A. Background
B. Hepatitis A
C. Hepatitis B
D. Hepatitis C
   CLASSIFICATION
   TRANSMISSION OF INFECTION
   OCCUPATIONAL HAZARDS
   ACUTE HEPATITIS
   DIAGNOSIS OF ACUTE INFECTION
   CHRONIC HEPATITIS
   HCV AND OTHER CHRONIC LIVER DISEASES
   ALCOHOLIC LIVER DISEASE
   HEPATITIS B COINFECTION
   CIRRHOSIS AND HEPATOCELLULAR CARCINOMA
   DIAGNOSTIC TESTS
   POSSIBLE INDICATIONS FOR HCV RNA TESTING
   CONCLUSIONS AND FUTURE DIRECTION
E. Hepatitis D
   HISTORICAL PERSPECTIVE
   EPIDEMIOLOGY
   HBV-HDV 'COINFECTION' VS. 'SUPERINFECTION'
   METHODS OF DETECTING HDV
   PREVENTION
F. Hepatitis E
   BACKGROUND
   PREVALENCE OF THE DISEASE
   DIAGNOSTIC TESTS
   EPIDEMIOLOGIC SEROSURVEYS
   SEROLOGIC CROSS-REACTIVITY
G. Hepatitis G
   VACCINES AND DRUGS
H. Review of Leading Analyzers Marketed by: Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
I. Emerging Diagnostic Technologies
   1. MOLECULAR DIAGNOSTICS
   2. MONOCLONAL ANTIBODIES
   3. IMMUNOASSAYS
   4. DIFFERENTIAL LIGHT SCATTERING
   5. INFORMATION TECHNOLOGY
   6. ARTIFICIAL INTELLIGENCE
   7. LIPOSOMES
   8. FLOW CYTOMETRY
   9. CHROMATOGRAPHY
   10. DIAGNOSTIC IMAGING
   11. GEL MICRODROPLETS
   12. OTHER
III. USA: Market Size, Growth and Major Suppliers’ Sales and Market Shares

X. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
   1. MARKETING APPROACHES
   2. PRODUCT COMPLEXITY
   3. CUSTOMER PREFERENCE
   4. ESTABLISHED SUPPLIERS
   5. EMERGING SUPPLIERS
   6. MAJOR TYPES OF DISTRIBUTORS
   7. MARKET SEGMENTATION

XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

XII. COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Enzo Biochem
Fujirebio/Innogenetics
Hologic/Gen-Probe
ID Biomedical/GSK
Kreatech
Life Technology
Lonza
Nanogen/Elitech
Novartis Diagnostics
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac/PE
Wako

List Of Tables

LIST OF TABLES

Major Companies Developing or Marketing Hepatitis Tests
U.S.A HAV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A HBV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. HBs Ag Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Hepatitis C Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Anti-HBc Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Anti-HBs Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Anti-HAV Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Hepatitis Delta Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. HBc Ag Test Volume and Diagnostics Sales Forecast by Market Segment
LIST OF TABLES
(Continued)
U.S.A. HBe Ag Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Hepatitis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Hepatitis C Testing Market Diagnostics Sales by Major Supplier